<DOC>
	<DOCNO>NCT00821782</DOCNO>
	<brief_summary>Evaluation bacteria mouth throat study drug ( Levofloxacin , floroquinolone antibiotic Azithromycin , macrolide antibiotic ) start periodically 6 week last dose study drug take</brief_summary>
	<brief_title>Evaluation Bacteria Mouth Throat Healthy Adults Before After Administration Either Levofloxacin Azithromycin , Both Antibiotic Medications</brief_title>
	<detailed_description>This randomize , open-label , single center , exploratory , Phase 1 study explore change resistance pattern bacteria oral flora healthy male female adult subject . The study enroll approximately 140 healthy subject . Approximately 70 subject receive levofloxacin daily 5 day 70 receive azithromycin daily 5 day . Male female healthy subject , 18 year old may participate . Subjects treat outpatient basis Phase 1 facility . Laboratory test ( blood urine collection ) microbiologic test ( throat swab ) perform dose study drug Study Entry ( Visit 1 ) . Subjects return daily test facility once-daily dose study drug Visits 2 5 total 5 consecutive day . At Visit 5 laboratory microbiologic test perform . Subjects return test facility 2-Week ( Visit 6 ) , 4-Week ( Visit 7 ) 6-Week ( Visit 8 ) Post-Therapy Visits undergo microbiologic testing ( throat swab ) . The primary endpoint emergence bacterial resistance oropharyngeal flora start prior initiation study drug 6-week observation period . Microbiologic test ( throat swab ) conduct prior dose Day 1 follow dosing Days 5 , 19 , 33 , 47 . Safety assessment conduct prior drug administration , study drug treatment , end-of-therapy visit . These include clinical laboratory evaluation , vital sign , physical examination , pregnancy testing , collection adverse event . Serious adverse event collect 30 day follow last dose study drug . Levofloxacin Once-Daily 750 mg PO For 5 Days And Azithromycin Once-Daily 500 mg PO On Day One And Then 250 mg On Days 2 Through 5</detailed_description>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Male female Healthy basis prestudy physical examination , medical history , laboratory result blood hematology , biochemistry , urinalysis perform within 24 hour first dose Renal function test must within normal laboratory reference range Normotensive sitting ( 5 minute ) blood pressure range 90 140 mmHg systolic , inclusive , 5090 mmHg diastolic , inclusive Normal temperature least 72 hour . Normal define &gt; 36.0 C ( 96.8 F ) &lt; 37.5 C ( 99.5 F ) Weight define BMI range 18 32 kg/m2 , inclusive Must read sign informed consent document first studyrelated procedure indicate understand purpose procedure require study willing participate study . History allergy serious adverse reaction levofloxacin quinolone azithromycin macrolide Clinically significant abnormal laboratory value Previous systemic antimicrobial therapy within 3 month Study Entry reason Hospitalized cause within 3 month prior Study Entry Current drug abuse , alcohol abuse , homelessness Requirement prescription nonprescription medication supplement vitamins herbal supplement , except paracetamol ( acetaminophen ) treatment headache pain , hormone replacement therapy , birth control medication upon study entry study conduct Pregnancy breastfeeding Has receive experimental drug medical device within previous 3 month involvement experimental protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Bacteria</keyword>
	<keyword>Oral flora bacteria</keyword>
	<keyword>Resistance</keyword>
</DOC>